Choose a trusted healthcare provider who puts you at the center of your care
Yes, fatigue is a common side effect of GLP-1 medications
The clinical trial evidence on duration The landmark STEP trials for semaglutide and SURMOUNT trials for tirzepatide provide the clearest data on what happens at different treatment durations
As a result, they usually resolve within a few days of the injection, and within a few weeks of longer-term use, says Fishman
Retatrutide , a triple-agonist targeting GLP-1, GIP, and glucagon receptors simultaneously, represents genuinely cutting-edge research
NAION is an eye condition that can develop without warning and cause irreversible blindness in one or both eyes